Published online January 3, 2005
PEDIATRICS Vol. 115 No. 1 January 2005, pp. e105-e108 (doi:10.1542/10.1542/peds.2004-0554)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oden, J.
Right arrow Articles by Cheifetz, I. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oden, J.
Right arrow Articles by Cheifetz, I. M.
Related Collections
Right arrow Endocrinology
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ELECTRONIC ARTICLE

Neonatal Thyrotoxicosis and Persistent Pulmonary Hypertension Necessitating Extracorporeal Life Support

Jon Oden, MD* and Ira M. Cheifetz, MD, FCCM{ddagger}

* Pediatric Endocrinology and Diabetes
{ddagger} Pediatric Critical Care Medicine, Duke Children's Hospital, Durham, North Carolina

We report a case of neonatal Graves' disease involving an infant with severe persistent pulmonary hypertension (PPHN) associated with neonatal thyrotoxicosis that necessitated extracorporeal membrane oxygenation. Hyperthyroidism, although uncommon in the newborn period, has been associated with pulmonary hypertension among adults. The exact mechanisms responsible for this effect on pulmonary vascular pressure are not well understood. Recent studies have provided evidence that thyrotoxicosis has direct and indirect effects on pulmonary vascular maturation, metabolism of endogenous pulmonary vasodilators, oxygen economy, vascular smooth muscle reactivity, and surfactant production, all of which may contribute to the pathophysiologic development of PPHN. Therefore, because PPHN is a significant clinical entity among term newborns and the symptoms of hyperthyroidism may be confused initially with those of other underlying disorders associated with PPHN (eg, sepsis), it would be prudent to perform screening for hyperthyroidism among affected newborns.

Key Words: Graves' disease • persistent pulmonary hypertension of the newborn • extracorporeal life support • extracorporeal membrane oxygenation • shock • respiratory failure • neonate • hypoxia • hypotension • tachycardia • oxygen delivery • thyrotoxicosis • thyroid • hyperthyroidism

Abbreviations: PPHN, persistent pulmonary hypertension • PVR, pulmonary vascular resistance • ECMO, extracorporeal membrane oxygenation • NO, nitric oxide • NOS, nitric oxide synthase • TTF-1, thyroid transcription factor-1 • ADMA, asymmetric NG,NG-dimethyl-L-arginine

Accepted Aug 16, 2004.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?